MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 5, 2014, Pages 351-357

  Xu, Quanfu ^a   Meng, Shu ^a   Liu, Bo ^a   Li, Mao Quan ^b   Li, Yeting ^a   Fang, Lu ^c   Li, Yi Gang ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Autophagy; Beclin1; Diabetes mellitus; Endothelial progenitor cells; miR 130a

Indexed keywords

BECLIN 1; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 130A; PROTEIN BCL 2; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MIRN130 MICRORNA, HUMAN; RUNX3 PROTEIN, HUMAN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSMISSION ELECTRON MICROSCOPY; CELL CULTURE; FLOW CYTOMETRY; GENETICS; LENTIVIRINAE; METABOLISM; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PLASMID; ULTRASTRUCTURE; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BLOTTING, WESTERN; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL PROGENITOR CELLS; FLOW CYTOMETRY; HUMANS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; MICRORNAS; MICROSCOPY, ELECTRON, TRANSMISSION; PLASMIDS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84899085190     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12227     Document Type: Article

References (36)

1. van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm. 2010; 2010: 792393.
2. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc. Res. 2008; 78: 413-21.
3. Jarajapu YP, Grant MB. The promise of cell-based therapies for diabetic complications: Challenges and solutions. Circ. Res. 2010; 106: 854-69.
4. Fadini GP, Sartore S, Albiero M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 2006; 26: 2140-6.
5. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001; 89: E1-7.
6. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-6.
7. Gustafsson AB, Gottlieb RA. Recycle or die: The role of autophagy in cardioprotection. J. Mol. Cell. Cardiol. 2008; 44: 654-61.
8. Moreau K, Luo S, Rubinsztein DC. Cytoprotective roles for autophagy. Curr. Opin. Cell Biol. 2010; 22: 206-11.
9. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009; 43: 67-93.
10. Murrow L, Debnath J. Autophagy as a stress-response and quality-control mechanism. Implications for cell injury and human disease. Annu. Rev. Pathol. 2012; 8: 105-37.
11. Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003; 301: 1387-91.
12. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013; 368: 651-62.
13. Gonzalez CD, Lee MS, Marchetti P et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011; 7: 2-11.
14. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ. 2009; 16: 31-8.
15. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2001; 2: 330-5.
16. Zou MH, Xie Z. Regulation of interplay between autophagy and apoptosis in the diabetic heart. New role of AMPK. Autophagy 2013; 9: 624-5.
17. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-33.
18. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482: 347-55.
19. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic. Progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 2011; 11: 849-64.
20. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J. Mol. Cell. Cardiol. 2012; 53: 64-72.
21. Meng S, Cao J, Zhang X et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS ONE 2013; 8: e68611.
22. Gump JM, Thorburn A. Autophagy and apoptosis: What is the connection? Trends Cell Biol. 2011; 21: 387-92.
23. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing. Crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007; 8: 741-52.
24. Huang Y, Chuang AY, Ratovitski EA. Phospho-DeltaNp63alpha/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle 2011; 10: 3938-47.
25. Zhu H, Wu H, Liu X et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009; 5: 816-23.
26. Korkmaz G, le Sage C, Tekirdag KA, Agami R, Gozuacik D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 2012; 8: 165-76.
27. Pattingre S, Tassa A, Qu X et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
28. Guo C, Ding J, Yao L et al. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int. J. Cancer 2005; 116: 155-60.
29. Masini M, Bugliani M, Lupi R et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009; 52: 1083-6.
30. Kovaleva V, Mora R, Park YJ et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012; 72: 1763-72.
31. Liao YF, Feng Y, Chen LL et al. Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell. J. Diabetes Complicat. 2014; 28: 214-18.
32. Chu CT. Autophagic stress in neuronal injury and disease. J. Neuropathol. Exp. Neurol. 2006; 65: 423-32.
33. Marsh BJ, Soden C, Alarcon C et al. Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine beta-cells. Mol. Endocrinol. 2007; 21: 2255-69.
34. Maiuri MC, Le Toumelin G, Criollo A et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007; 26: 2527-39.
35. Kunchithapautham K, Rohrer B. Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy 2007; 3: 433-41.
36. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners. Apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009; 16: 966-75.